Keywords: Abbott Labs, First-qurter 2012 financial results
Abbott beats forecasts as 1st-qtr sees strong sales and earnings growth
Article | 19 April 2012
US health care major Abbott Laboratories (NYSE: ABT) pleased investors yesterday, reporting better-than-expected first-quarter 2011 financial results. Excluding foreign exchange, worldwide ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
